ABERNATHY JAMES PAUL 4

What Happened

• James P. Abernathy, a director of National Healthcare Corp (NHC), exercised stock options on March 9, 2026 to acquire 3,140 shares at an exercise price of $55.75 per share, for a total cash cost of $175,055. The filing also reports a derivative-line entry for 3,140 shares at $0.00 reflecting the option conversion/derivative reporting associated with the exercise. This transaction is an acquisition (exercise of options), not an open-market sale.

Key Details

• Transaction date: 2026-03-09; Filing date: 2026-03-10 (timely)
• Exercise: 3,140 shares acquired at $55.75 per share (total = $175,055)
• Derivative reporting: 3,140 shares listed as disposed at $0.00 (represents the option-to-stock conversion reporting)
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan on May 4, 2023; the grant and exercise are exempt from Section 16(b) under Rule 16b-3(d)

Context

• This was an option exercise (insider acquired company shares by converting options). The filing does not show an immediate sale of the acquired shares on the open market. Such exercises are common for option holders and do not by themselves indicate a buy/sell opinion; they reflect the insider exercising compensation-related rights.